Triphala Powder | whatsinit

About

What it is and where it shows up.

Triphala is a traditional Ayurvedic polyherbal powder composed of equal parts of three dried fruits: Emblica officinalis (Amalaki), Terminalia bellirica (Bibhitaki), and Terminalia chebula (Haritaki). It is used as a health supplement and nutraceutical for gastrointestinal support, antioxidant effects, immunomodulation, and general rejuvenation.

Safety summary

The regulatory and scientific consensus.

Acute and chronic toxicity studies in rats at doses up to 5000 mg/kg (acute) and 2400 mg/kg/day for 270 days found no significant toxic effects, and a human Phase I clinical trial at 2500 mg/day showed no serious adverse effects. However, Triphala inhibits key cytochrome P450 enzymes (CYP1A2, CYP3A4, CYP2C9, CYP2D6), raising concerns about pharmacokinetic herb-drug interactions. No formal Acceptable Daily Intake (ADI) has been established by any major global regulatory authority.

Regulatory landscape

What food-safety regulators have decided.

Jurisdiction	Status	Note
FSSAI (Food Safety and Standards Authority of India) (India)	Approved	Triphala is permitted as a plant/botanical ingredient under Schedule II of the FSS (Health Supplements, Nutraceuticals, Food for Special Dietary Use, Food for Special Medical Purpose, Functional Food and Novel Food) Regulations, 2016. It may be used as a health supplement or nutraceutical. Health claims require prior approval from FSSAI. Minimally processed botanical powders in non-supplement food contexts are regulated separately.source
FDA (Food and Drug Administration) (United States)	Approved	Triphala is marketed as a dietary supplement in the US under DSHEA (1994). It is not listed as a food additive or GRAS substance; manufacturers assume full responsibility for product safety. No specific FDA approval or maximum daily intake has been established for Triphala powder.source
EFSA (European Food Safety Authority) (European Union)	Under_review	Triphala is not specifically evaluated or authorized as a food supplement ingredient by EFSA. Botanical food supplements in the EU are governed by national regulations in the absence of a harmonized EU-positive list. Triphala-based supplements are commercially available in several EU member states but lack a centralized EFSA opinion or authorized health claim.source

Who should approach with care

Whose guidance would steer them away.

Pregnancy — Traditional Ayurvedic texts and standard herbal supplement guidance recommend caution during pregnancy due to Triphala's stimulant laxative properties and lack of controlled human safety data in pregnant women.

Lactation — Insufficient controlled data exist on the transfer of Triphala's bioactive polyphenols (gallic acid, ellagic acid) into breast milk; standard botanical supplement caution applies.

Infants — No safety data exist for use of Triphala in infants; it is not approved or indicated for this age group under any regulatory framework.

Children — Pediatric-specific safety and dosing data for Triphala are absent from the clinical literature; use should be under medical supervision only.

Diabetes — Triphala significantly lowers blood glucose levels by inhibiting alpha-amylase and alpha-glucosidase; concurrent use with antidiabetic medications may cause additive hypoglycemia.

Research citations

The sources behind this verdict.

1PubMed. Safety of the Oral Triphala Recipe from Acute and Chronic Toxicity Tests in Sprague-Dawley Rats, 2022. pubmed.ncbi.nlm.nih.gov
2PubMed. Inhibitory effects of Triphala on CYP isoforms in vitro and its pharmacokinetic interactions with phenacetin and midazolam in rats, 2022. pmc.ncbi.nlm.nih.gov
3FSSAI. Food Safety and Standards (Health Supplements, Nutraceuticals…) Regulations Compendium, 2021, 2021. fssai.gov.in
4PubMed. Effects of Triphala on Lipid and Glucose Profiles and Anthropometric Parameters: A Systematic Review, 2021. pmc.ncbi.nlm.nih.gov
5PubMed. Study of the safety of oral Triphala aqueous extract on healthy volunteers, 2020. pubmed.ncbi.nlm.nih.gov
6PubMed. Therapeutic Uses of Triphala in Ayurvedic Medicine, 2017. pmc.ncbi.nlm.nih.gov

Independently researched6 citations